Related Experiment Video
Updated: Jun 28, 2025
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Predictive Role of Platelet and Inflammation Markers for Severe COVID-19 by Propensity Score Matching
Insights
Platelet count and inflammation markers like high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) can predict severe COVID-19. Reduced platelet counts and P/F ratios, alongside elevated hsCRP and IL-6, indicate higher risk.
Area of Science:
- Medical research
- Infectious diseases
- Hematology
- Immunology
Background:
- COVID-19 poses a significant global health challenge.
- Identifying early predictors of severe disease is crucial for patient management.
- Platelet and inflammation markers are potential indicators of disease severity.
Purpose of the Study:
- To evaluate the predictive value of platelet and inflammation markers for severe COVID-19.
- To analyze the correlation between laboratory parameters and COVID-19 severity.
- To identify key biomarkers associated with critical illness in COVID-19 patients.
Main Methods:
- Retrospective real-world cohort study.
- Propensity score matching (PSM) to control for confounding factors.
- Classification of patients into severe and non-severe COVID-19 groups.
- Analysis of laboratory parameters at admission, including platelet count, hsCRP, IL-6, and P/F ratio.
Main Results:
- Severe COVID-19 cases showed significantly higher median age and increased prevalence of diabetes comorbidity.
- Elevated levels of high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) were observed in severe cases.
- Reduced platelet count and P/F ratio were significantly associated with severe COVID-19 after PSM.
- Independent risk factors for severe COVID-19 included age, diabetes, fever, respiratory symptoms, platelet count, hsCRP, IL-6, and P/F ratio.
Conclusions:
- Elevated hsCRP and IL-6 levels are significant indicators of severe COVID-19.
- Reduced platelet count and P/F ratio at admission are associated with increased COVID-19 severity.
- These laboratory markers may serve as valuable predictive tools for identifying patients at risk of severe COVID-19.
Background:
This study aims to ascertain the predictive value of platelet and inflammation markers in severe cases of COVID-19.
Methods:
A retrospective real-world cohort study was conducted using propensity score matching (PSM). Patients were classified into severe and non-severe COVID-19 groups based on the severity of the disease, and the correlation between severe COVID-19 and laboratory parameters at admission was analyzed.
Results:
The study included 397 adult patients, comprising 212 (53%) males and 185 (47%) females. Among these, 309 were non-severe and 88 were severe cases. The severe group had a higher median age than the non-severe group (60 vs. 42 years, p < 0.001). Independent risk factors for severe COVID-19 included age, diabetes comorbidity, fever, respiratory symptoms, platelet count, high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and the ratio of arterial oxygen partial pressure (PaO2) to the fraction of inspired oxygen (FiO2) (P/F ratio). After one-to-one PSM, adjusted for age, diabetes comorbidities, fever, and respiratory symptoms, significant differences in laboratory parameters at admission were observed. Compared to the non-severe group (n = 71), in the severe group (n = 71), elevated levels of hsCRP (median: 27.1 mg/L vs. 14.6 mg/L, p = 0.005) and IL-6 (median: 16.2 pg/mL vs. 15.3 pg/mL, p = 0.005) were observed, while platelet count (164 ± 36 × 109 vs. 180 ± 50 × 109, p = 0.02) and P/F ratio (median: 351 vs. 397, p = 0.001) were reduced.
Conclusions:
Elevated levels of hsCRP and IL-6, along with reduced platelet count and P/F ratio at admission, were significantly associated with severe COVID-19 and may serve as predictive indicators.
More Related Videos
Related Concept Videos
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...